At 5.9% CAGR, the South & Central America Pulmonary Function Testing Systems Market is projected to be worth US$ 24.11 million by 2028, says Business Market Insights

According to Business Market Insights research, the South & Central America pulmonary function testing systems market was valued at US$ 17.10 million in 2022 and is expected to reach US$ 24.11 million by 2028, registering a CAGR of 5.9% from 2022 to 2028. Rising incidence of lung-related disorders and workplace pulmonary function testing systems are the critical factors attributed to the South & Central America pulmonary function testing systems market expansion. 

Occupational lung disease is one of the most influential factors accelerating the demand for pulmonary function testing systems. For example, in certain occupations, people are more at risk of occupational lung diseases due to the nature of the location, work, and environment. Additionally, people working in a car garage or textile factory may be exposed to hazardous chemicals, dust, and fibers that result in lifetime lung problems if not diagnosed and treated. Moreover, asbestosis is caused by the inhalation of microscopic fibers of asbestos with disease progression and resulting in scarring of the lungs of people working in construction, manufacturing, and chemical refining. Whereas , pulmonary function testing systems used in the diagnosis of lung disease. Therefore, occupational lung diseases were driving the South & Central America pulmonary function testing systems market growth during the forecast period.

On the contrary, risk of cross-contamination and lack of skilled professionals hampers the South & Central America pulmonary function testing systems market.

Based on type, the South & Central America pulmonary function testing systems market is segmented into cart-based pft systems and stationery pft systems. The cart-based pft systems segment held 76.9% share of South & Central America pulmonary function testing systems market in 2022, amassing US$ 13.14 million. It is projected to garner US$ 18.82 million by 2028 to expand at 6.2% CAGR during 2022–2028.

Based on test type, the South & Central America pulmonary function testing systems market is segmented into spirometry, lung volume, gas exchange testing, maximum voluntary ventilation, oxygen titration test, and others. The spirometry segment held 44.6% share of South & Central America pulmonary function testing systems market in 2022, amassing US$ 7.63 million. It is projected to garner US$ 10.88 million by 2028 to expand at 6.1% CAGR during 2022–2028.

Based on component, the South & Central America pulmonary function testing systems market is segmented into hardware, software, and services. The hardware segment held 42.0% share of South & Central America pulmonary function testing systems market in 2022, amassing US$ 7.19 million. It is projected to garner US$ 10.07 million by 2028 to expand at 5.8% CAGR during 2022–2028. 

Based on application, the South & Central America pulmonary function testing systems market is segmented into chronic obstructive pulmonary disorder, asthma, chronic shortness of breath, restrictive lung disease, and others. The chronic obstructive pulmonary disorder segment held 36.0% share of South & Central America pulmonary function testing systems market in 2022, amassing US$ 6.16 million. It is projected to garner US$ 8.82 million by 2028 to expand at 6.2% CAGR during 2022–2028.

Based on end-user, the South & Central America pulmonary function testing systems market is segmented into hospitals, specialty clinics, and diagnostic laboratories. The hospitals segment held 46.5% share of South & Central America pulmonary function testing systems market in 2022, amassing US$ 7.95 million. It is projected to garner US$ 11.41 million by 2028 to expand at 6.2% CAGR during 2022–2028.

Based on country, the South & Central America pulmonary function testing systems market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Our regional analysis states that the Rest of South & Central America captured 38.0% share of South & Central America pulmonary function testing systems market in 2022. It was assessed at US$ 6.50 million in 2022 and is likely to hit US$ 9.00 million by 2028, exhibiting a CAGR of 5.6% during the forecast period.      

Key players dominating the South & Central America pulmonary function testing systems market are COSMED Srl; MGC Diagnostics Corp; Schiller AG; and Vyaire Medical Inc, and among others. 

• In April 2021; Vyaire Medical announced the global  launch of ArtiQ.PFT, an automated tool driven by artificial intelligence that instantly interprets pulmonary function tests (PFTs). ArtiQ.PFT is the first cloud-based PFT-solution that leverages artificial intelligence.

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com